Point72 Asset Management
EXAS

Point72 Asset Management’s Exact Sciences EXAS Stock Holding History

Point72 Asset Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-180,575
Closed -$18.3M – 3996
2025
Q4 		$18.3M Buy
+180,575
New +$14.5M 0.02% 945
2025
Q1 		– Sell
-71,192
Closed -$4M – 2184
2024
Q4 		$4M Buy
+71,192
New +$4.43M 0.01% 1022
2024
Q3 		– Sell
-195,770
Closed -$8.27M – 2092
2024
Q2 		$8.27M Sell
195,770
-1,774,004
-90% -$97.6M 0.02% 675
2024
Q1 		$136M Buy
1,969,774
+680,583
+53% +$43M 0.33% 54
2023
Q4 		$95.4M Buy
1,289,191
+921,740
+251% +$60.4M 0.23% 99
2023
Q3 		$25.1M Sell
367,451
-823,485
-69% -$69.9M 0.07% 344
2023
Q2 		$112M Sell
1,190,936
-288,361
-19% -$22.5M 0.33% 68
2023
Q1 		$100M Buy
1,479,297
+305,388
+26% +$19.6M 0.31% 68
2022
Q4 		$58.1M Sell
1,173,909
-1,257,002
-52% -$51.4M 0.2% 130
2022
Q3 		$79M Buy
+2,430,911
New +$100M 0.32% 72
2022
Q2 		– Sell
-24,100
Closed -$1.69M – 1459
2022
Q1 		$1.69M Buy
+24,100
New +$1.76M 0.01% 900
2021
Q3 		– Sell
-14,299
Closed -$1.78M – 1100
2021
Q2 		$1.78M Buy
+14,299
New +$1.71M 0.01% 746
2020
Q3 		– Sell
-200,200
Closed -$17.4M – 977
2020
Q2 		$17.4M Buy
+200,200
New +$16M 0.11% 235
2019
Q3 		– Sell
-110,898
Closed -$13.1M – 1219
2019
Q2 		$13.1M Buy
110,898
+105,850
+2,097% +$10.7M 0.07% 336
2019
Q1 		$437K Sell
5,048
-89,552
-95% -$7.62M ﹤0.01% 877
2018
Q4 		$5.97M Buy
+94,600
New +$6.49M 0.03% 520
2018
Q2 		– Sell
-576,800
Closed -$23.3M – 1033
2018
Q1 		$23.3M Buy
576,800
+29,994
+5% +$1.46M 0.1% 264
2017
Q4 		$28.7M Buy
+546,806
New +$29.2M 0.12% 226
2017
Q3 		– Sell
-455,200
Closed -$16.1M – 925
2017
Q2 		$16.1M Sell
455,200
-2,045,276
-82% -$63.1M 0.09% 299
2017
Q1 		$59.1M Buy
2,500,476
+2,347,476
+1,534% +$46.5M 0.33% 73
2016
Q4 		$2.04M Buy
+153,000
New +$2.47M 0.01% 562
2016
Q3 		– Sell
-507,175
Closed -$6.21M – 756
2016
Q2 		$6.21M Sell
507,175
-240,325
-32% -$1.81M 0.04% 383
2016
Q1 		$5.04M Sell
747,500
-1,721,328
-70% -$11M 0.04% 426
2015
Q4 		$22.8M Buy
2,468,828
+2,456,828
+20,474% +$22.8M 0.19% 147
2015
Q3 		$216K Sell
12,000
-62,400
-84% -$1.43M ﹤0.01% 685
2015
Q2 		$2.21M Sell
74,400
-84,500
-53% -$2.12M 0.02% 566
2015
Q1 		$3.5M Sell
158,900
-2,323,500
-94% -$58.9M 0.02% 492
2014
Q4 		$68.1M Buy
2,482,400
+2,014,200
+430% +$49M 0.48% 51
2014
Q3 		$9.07M Buy
+468,200
New +$8.58M 0.07% 297

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Point72 Asset Management's EXAS Position: Q1 2026 in Review

Point72 Asset Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 180,575 shares — an estimated $18.3M sold.

Point72 Asset Management first reported a position in EXAS in Q3 2014 and held it in 29 quarters. The position peaked at $136M in Q1 2024. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Point72 Asset Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Point72 Asset Management sold 180,575 Exact Sciences shares in Q1 2026, an estimated $18.3M.
  • Point72 Asset Management first reported a position in Exact Sciences in Q3 2014 and held it in 29 quarters.
  • Point72 Asset Management's Exact Sciences position peaked at $136M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.